ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,728Medicare Part D Prescriptions Filled, Including Refills

Rank: 157 out of 2035

$672K Total Retail Price of All Prescriptions

Rank: 155 out of 2035

234 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 234 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

24% of this provider’s 234 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 9,394 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

46 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
SIMVASTATIN 442 415 1 1
HYDROCODONE-ACETAMINOPHEN 322 283 S3 2 2
LEVOTHYROXINE SODIUM 313 276 3 4
QUETIAPINE FUMARATE 312 265 4 70
FUROSEMIDE 296 255 5 7
DONEPEZIL HCL 286 272 6 24
RISPERIDONE 274 219 7 68
LISINOPRIL 260 218 8 3
NAMENDA 242 220 9 37
OMEPRAZOLE 230 203 10 5
GENERLAC 226 226 11 180
LANTUS 223 203 12 40
MIRTAZAPINE 211 183 13 46
METOPROLOL TARTRATE 198 169 14 8
CITALOPRAM HBR 192 175 15 20
SERTRALINE HCL 185 159 16 23
LIDODERM 171 159 17 72
AMLODIPINE BESYLATE 157 153 18 6
GABAPENTIN 155 139 19 14
OLANZAPINE 154 143 20 121
TRAMADOL HCL 147 114 21 19
JANTOVEN 144 120 22 138
KLOR-CON M20 138 117 23 73
CLOZAPINE 115 94 24 200
SEROQUEL 113 104 25 153
DIVALPROEX SODIUM 108 92 26 75
ESCITALOPRAM OXALATE 99 99 27 77
TAMSULOSIN HCL 99 89 27 25
SPIRIVA 96 82 29 44
TRAZODONE HCL 95 77 30 50
CARVEDILOL 93 88 31 22
METOPROLOL SUCCINATE 91 68 32 16
FENTANYL 90 90 S2 33 53
CARBIDOPA-LEVODOPA 87 76 34 94
OXYBUTYNIN CHLORIDE ER 86 86 35 117
NYSTATIN 85 77 36 103
CLOPIDOGREL 80 72 37 30
ATORVASTATIN CALCIUM 80 79 37 13
CEPHALEXIN 79 71 39 91
KLOR-CON M10 79 53 39 158
FAMOTIDINE 77 60 41 71
OXCARBAZEPINE 68 59 42 317
ALENDRONATE SODIUM 66 63 43 27
TRIAMCINOLONE ACETONIDE 66 66 43 142
NOVOLOG 64 63 45 95
LOSARTAN POTASSIUM 64 64 45 15
PREDNISONE 64 55 45 36
GLIPIZIDE 64 64 45 54
PAROXETINE HCL 63 61 49 69
TRICOR 62 62 50 120
PHENYTOIN 61 60 51 268
ACTOS 59 59 52 124
ISOSORBIDE MONONITRATE ER 58 58 53 32
ADVAIR DISKUS 57 43 54 38
IPRATROPIUM-ALBUTEROL 56 37 55 146
LANTUS SOLOSTAR 55 45 56 66
HUMALOG 54 35 57 139
ATENOLOL 50 49 58 10
DIVALPROEX SODIUM ER 50 49 58 226
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 24, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.